Corticosteroids for severe sepsis;Corticothérapie dans les états infectieux graves

Bulletin de l'Academie Nationale de Medecine

Volumn 184, Issue 8, 2000, Pages 1631-1640

  Annane, Djillali ^a   Sharshar, Tarek ^b   Auriant, Igor ^b   Clair, Bernard ^b   Raphael, Jean Claude ^b   Gajdos, Philippe ^b  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CYTOKINE; STEROID;

CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INFLAMMATION; INTENSIVE CARE; METHODOLOGY; MORBIDITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPTIC SHOCK; SURVIVAL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CAUSE OF DEATH; CRITICAL CARE; CYTOKINES; HUMANS; INFLAMMATION; MORBIDITY; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; STEROIDS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034562802     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. BONE R.C. - Sepsis, the sepsis syndrome, multi-organ failure : a plea for comparable definitions. Ann Intern Med, 1991, 114, 332-333.
2. MEMBERS OF THE AMERICAN COLLEGE OF CHEST PHYSICIANS/SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE COMMITTEE. - American College of Chest Physicians / Society of Critical Care Medicine Consensus Conference : Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 1992, 20, 864-874.
3. CENTER FOR DISEASE CONTROL AND PREVENTION. NATIONAL CENTER FOR HEALTH STATISTICS. -Annual summary of births, marriages, divorces and deaths, 1993. Mon Vital Stat Rep, 1994, 42, 5-10.
4. SANDS K.E., BATES D.W., LANKEN P.N. et al. - Epidemiology of sepsis syndrome in 8 academic medical center. JAMA, 1997, 278, 234-240.
5. BRUN-BUISSON C., DOYON F., CARLET J. et al. - Incidence, risk factors, and outcome of severe sepsis and septic shock in adults : a multicenter prospective study in intensive care units. JAMA, 1995, 274, 968-974.
6. PARRILLO J.E. - Pathogenic mechanisms of septic shock. N Engl J Med, 1993, 328, 1471-1477.
7. CHROUSOS G. P. - The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med, 1995, 322, 1351-1362.
8. HOTTA M., BAIRD A. - Differential effects of transforming growth factor type beta on the grouth and function of adrecortical cells in vitro. Proc Nat Acad Sci USA, 1986, 83, 7795-7799.
9. JÄÄTTELÄ M., ILVEMÄSKI V., VOUTILAINEN R., STENMAN U.H., SAKSELA E. - Tumor necrosis factor as a potent inhibitor of adrecorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology, 1991, 128, 623-629.
10. ROTHWELL P.M., UDWADIA Z.F., LAWLER P.G. - Cortisol response to corticotropin and survival in septic shock. Lancet, 1991, 337, 582-583.
11. ANNANE D., SÉBILLE V., TROCHÉ G., RAPHAËL J.C., GAJDOS P., BELLISSANT E. - A three-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA, 2000, 283, 1038-1045.
12. MEDURI G.U., CHROUSOS G.P. - Duration of glucocorticoid treatment and outcome in sepsis : is the right drug used the wrong way ? Chest, 1998, 114, 355-359.
13. ZONGHAI H., HAN G., RENBAO X. - Study on glucocorticoid receptors during intestinal ischemia shock and septic shock. Circ Res, 1987, 23, 27-36.
14. BARNES P.J., GREENING A.P., CROMPTON G.K. - Glucocorticoid resistance in asthma. Am J Respir Crit Care Med, 1995, 152, S125-S140.
15. MOLIJN G.J., KOPER J.W., VAN UFFELEN C.J., et al. - Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocytes in patients with sepsis and septic shock. Clin Endocrinol, 1995, 43, 197-203.
16. FABIAN T.C., PATTERSON R. - Steroid therapy in septic shock. Survival studies in a laboratory model. Am Surg, 1982, 48, 614-617.
17. CALANDRA T., BERNHAGEN J., METZ C.N. et al. - MIF as a glucocorticoid-induced modulator of cytokine production. Nature, 1995, 377, 68-71.
18. SCHUMER W. - Steroids in the treatment of clinical septic shock. Ann Surg, 1976, 184, 333-339.
19. CRONIN L., COOK D., CARLET J., HEYLAND D.K., KING D., LANSANG M.A., FISHER C.J. -Corticosteroid treatment for sepsis : a critical appraisal and meta-analysis of the literature. Crit Care Med. 1995, 23, 1430-1439.
20. BOLLAERT P.E., CHARPENTIER C., LEVY B., DEBOUVERIE M., AUDIBERT G., LARCAN A. -Reversal of late septic shock with supraphysiological doses of hydrocortisone. Crit Care Med, 1998, 26, 645-650.
21. BRIEGEL J., FORST H., HALLER M., et al. - Stress doses of hydrocortisone reverse hyperdynamic septic shock : a prospective, randomized, double-blind single-center study. Crit Care Med. 1999, 27, 723-732.
22. CHAWLA K., KUPFER Y., TESSLER S. - Hydrocortisone reverses refractory septic shock. Crit Care Med, 1999, 27, A33.
23. SANTOS A.A., SCHELTINGA M.R., LYNCH E. et al. - Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch Surg. 1993, 128, 138-144.
24. BARBER A.E. - Effects of hypercortisolemia on markers and patterns of the immune response. J Anästh Intens, 1999, 1, S195-S196.
25. BRIEGEL J., KELLERMANN W., FORST H. et al. - Low dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. Clin Investig, 1994, 72, 782-787.
26. KEY D. - Effects of hydrocortisone on the immune response in patients with septic shock results from a double-blind cross-over study. J Anästh Intens, 1999, 1, S195-S196.
27. ANNANE D., BELLISSANT E., SEBILLE V. et al. - Impaired pressor sensitivity to norepinephrine in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol, 1998, 46, 591-599.
28. BELLISSANT E., ANNANE D. - Effect of 50 mg hydrocortisone bolus on phenylephrine-mean arterial pressure dose response relationship in septic shock patients. Clin Pharmacol Ther, 2000, 68, 293-303.
29. MEDURI G.U., HEADLEY A.S., GOLDEN E., CARSON S.J., UMBERGER R.A., KELSO T., TOLLEY E.A. - Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome : a randomized controlled trial. JAMA, 1998, 280, 159-65.
30. HOFFMANN S.L., PUNJABI N.H., KUMALA S. et al. - Reduction of mortality in chloramphenicol-treated severe typhoid fever by high dose dexamethasone. N Engl J Med, 1984, 310, 82-88.
31. LEBEL M.H., FREIJ B.J., SYROGIANNOPOULOS G.A. et al. - Dexamethasone therapy for bacterial meningitis : results of two double blind, placebo-controlled trials. N Engl J Med, 1988, 319, 964-971.
32. MONTANER J.S., LAWSON L.M., LEVITT N., BELZBERG A., SCHECHTER M.T. - Corticosteroids prevent early deterioration in patients with moderately severe pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome. Ann Intern Med, 1990, 113.
33. SPRUNG C.L., CARALIS P.V., MARCIAL E.H. et al. - The effect of high dose corticosteroids in patients with septic shock. N Engl J Med, 1984, 311, 1137-1143.
34. SCHNEIDER A.J., VOERMAN H.J. - Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids. Intens Care Med, 1991, 17, 436-437.
35. BENFIELD K., COOPER D.J., SCHEINKESTEL C.D., TUXEN D.V. - Relative adrenal insufficiency in patients with septic shock. Anaesth Intens Care, 1994, 22, 215-216.
36. BRIEGEN J., FORST H., HELLINGER H., HALLER M. - Contribution of cortisol deficiency to septic shock. Lancet, 1991, 338, 507-508.
37. SCHELLING G., STOLL C., KAPFHAMMER H.P. et al. - The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors. Crit Care Med, 1999, 27, 2678-83.